197 related articles for article (PubMed ID: 26005019)
21. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
Ringleb PA; Schellinger PD; Schranz C; Hacke W
Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
[TBL] [Abstract][Full Text] [Related]
22. Identifying implications of thrombolysis for stroke rehabilitation: knowledge gaps in current research.
Finch E; Hayward KS; Fleming J; Copland DA
Disabil Rehabil; 2013 Jun; 35(11):924-30. PubMed ID: 23061414
[TBL] [Abstract][Full Text] [Related]
23. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
[TBL] [Abstract][Full Text] [Related]
24. Gaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: exploring the problem.
Nikkhah K; Avan A; Shoeibi A; Azarpazhooh A; Ghandehari K; Foerch C; Saposnik G; Sasannejad P; Vakili V; Layegh P; Farzadfard MT; Bavarsad Shahripour R; Hosseini MR; Azarpazhooh MR
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):408-15. PubMed ID: 25511616
[TBL] [Abstract][Full Text] [Related]
25. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
Kappelle LJ; van der Worp HB
Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
[TBL] [Abstract][Full Text] [Related]
26. Interdisciplinary rehabilitation outcomes following thrombolysis for acute ischaemic stroke: a case series.
Finch E; Fleming J; Clark K; Hayward KS
NeuroRehabilitation; 2014; 35(1):9-16. PubMed ID: 24990002
[TBL] [Abstract][Full Text] [Related]
27. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
Williams JM; Navin TJ; Jude MR; Levi CR
Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
[TBL] [Abstract][Full Text] [Related]
28. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
Wardlaw JM; Sandercock PA; Berge E
Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
[TBL] [Abstract][Full Text] [Related]
29. Promoting Acute Thrombolysis for Ischaemic Stroke (PRACTISE).
Dirks M; Niessen LW; Huijsman R; van Wijngaarden J; Minkman MM; Franke CL; van Oostenbrugge RJ; Koudstaal PJ; Dippel DW;
Int J Stroke; 2007 May; 2(2):151-9. PubMed ID: 18705977
[TBL] [Abstract][Full Text] [Related]
30. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
31. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Sandercock P; Lindley R; Wardlaw J; Dennis M; Innes K; Cohen G; Whiteley W; Perry D; Soosay V; Buchanan D; Venables G; Czlonkowska A; Kobayashi A; Berge E; Slot KB; Murray V; Peeters A; Hankey GJ; Matz K; Brainin M; Ricci S; Cantisani TA; Gubitz G; Phillips SJ; Antonio A; Correia M; Lyrer P; Kane I; Lundstrom E;
Trials; 2011 Nov; 12():252. PubMed ID: 22129158
[TBL] [Abstract][Full Text] [Related]
32. Efforts to reduce the door-to-needle time of thrombolysis in acute ischemic stroke: video-assisted therapeutic risk communication.
Hsieh CY; Chen WF; Chen CH; Wang CY; Chen CJ; Lai EC; Chen TS
J Formos Med Assoc; 2014 Dec; 113(12):929-33. PubMed ID: 24412584
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
[TBL] [Abstract][Full Text] [Related]
34. Early phase combined therapeutic management of acute ischaemic stroke.
Bassi P; Lattuada P; Tonietti S
Neurol Sci; 2005 May; 26 Suppl 1():S29-30. PubMed ID: 15883687
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
Kremer C; Kappelin J; Perren F
J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
[TBL] [Abstract][Full Text] [Related]
36. The effect of time to treatment on outcome in very elderly thrombolysed stroke patients.
Frank B; Fulton RL; Lees KR;
Int J Stroke; 2014 Jul; 9(5):591-6. PubMed ID: 24588833
[TBL] [Abstract][Full Text] [Related]
37. Facial angioedema and stroke.
Werner R; Keller M; Woehrle JC
Cerebrovasc Dis; 2014; 38(2):101-6. PubMed ID: 25277776
[TBL] [Abstract][Full Text] [Related]
38. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor.
Huang P; Chen CH; Yang YH; Lin RT; Lin FC; Liu CK
Cerebrovasc Dis; 2006; 22(5-6):423-8. PubMed ID: 16912476
[TBL] [Abstract][Full Text] [Related]
39. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
40. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH
Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
